ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

Toronto-based Bird&Be, which sells fertility supplements and test kits, raised a $13-million USD Series A co-led by BDC's Thrive Fund and BFG Partners. The round closed in August. The profitable company reports nearly 100-percent year-over-year growth and an eight-figure brand, with about 75 percent of direct-to-consumer revenue from subscriptions.
Tap to vote and see what everyone thinks.
Summary by ByteBrief
A5X Raises $70M Series D